Germany
Japan
United Kingdom
China
Centrosome Marker Antibodies
View as table Download
Rabbit Polyclonal antibody to GCP2 (tubulin, gamma complex associated protein 2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 1 and 226 of GCP2 (Uniprot ID#Q9BSJ2) |
Rabbit Polyclonal antibody to MP1 (MAPK scaffold protein 1)
| Applications | IHC, WB |
| Reactivities | Human (Predicted: Mouse, Bovine, X. tropicalis) |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 1 and 124 of MP1 (Uniprot ID#Q9UHA4) |
Rabbit polyclonal Plk1 phospho T210 antibody
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Anti-Polo-like Kinase pT210 Antibody was produced by repeated immunizations with a synthetic phospho peptide corresponding to aa 205-214 of Human Polo-like kinase 1 (Plk1) protein. |
Rabbit Polyclonal Anti-RAD51 Antibody
| Applications | IHC, WB |
| Reactivities | Mouse, Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-RAD51 Antibody: synthetic peptide directed towards the N terminal of human RAD51. Synthetic peptide located within the following region: ANDVKKLEEAGFHTVEAVAYAPKKELINIKGISEAKADKILVMAERYGLS |
Rabbit Polyclonal Anti-GNAI1 Antibody
| Applications | WB |
| Reactivities | Mouse, Human, Rat |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-GNAI1 antibody: synthetic peptide directed towards the middle region of human GNAI1. Synthetic peptide located within the following region: YQLNDSAAYYLNDLDRIAQPNYIPTQQDVLRTRVKTTGIVETHFTFKDLH |
Active filters
Isotypes
- IgG
Filter by
Category
Target Symbol
- BETA CATENIN (22)
- CDK1 (17)
- MAP2K1 (17)
- CDK2 (14)
- CTNNB1 (11)
- MEK1 (11)
- RAD51 (11)
- ALPHA SYNUCLEIN (9)
- XRCC3 (7)
- GAMMA TUBULIN (6)
- PDCD6IP (6)
- PLK1 (6)
- CDK2AP1 (5)
- CDC2 (4)
- GNAI2 (4)
- PLK4 (4)
- BETA SYNUCLEIN (3)
- BUB1B (3)
- GAMMA SYNUCLEIN (3)
- GNAI1 (3)
- NUMA (3)
- RAD51L1 (3)
- XRCC2 (3)
- BUBR1 (2)
- CDK2AP2 (2)
- CTNNBL1 (2)
- G PROTEIN ALPHA INHIBITOR 1 (2)
- G PROTEIN ALPHA INHIBITOR 2 (2)
- MAP2K1IP1 (2)
- NUMA1 (2)
- PERICENTRIN 1 (2)
- RAD51AP1 (2)
- RAD51C (2)
- RAD51D (2)
- TUBG1 (2)
- C20ORF19 (1)
- GAMMA TUBULIN COMPLEX COMPONENT 3 (1)
- IL20 (1)
- LAMTOR3 (1)
- NIN (1)
- NINL (1)
- NUP85 (1)
- PCNT (1)
- QSOX1 (1)
- RAD51B (1)
- SNCA (1)
- TUBG2 (1)
- TUBGCP2 (1)
- TUBGCP3 (1)
Reactivities
Antibody Hosts
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Assay Types
Families
Pathways
- Pathways in cancer (49)
- Progesterone-mediated oocyte maturation (44)
- Prostate cancer (42)
- Oocyte meiosis (40)
- Melanogenesis (37)
- Colorectal cancer (33)
- Endometrial cancer (33)
- Focal adhesion (33)
- Thyroid cancer (33)
- Cell cycle (31)
- Gap junction (30)
- Leukocyte transendothelial migration (26)
- Tight junction (26)
- p53 signaling pathway (24)
- Adherens junction (22)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (22)
- Basal cell carcinoma (22)
- Homologous recombination (22)
- Pathogenic Escherichia coli infection (22)
- Wnt signaling pathway (22)
- Pancreatic cancer (18)
- Chemokine signaling pathway (15)
- Long-term depression (15)
- MAPK signaling pathway (13)
- Acute myeloid leukemia (11)
- B cell receptor signaling pathway (11)
- Bladder cancer (11)
- Chronic myeloid leukemia (11)
- Dorso-ventral axis formation (11)
- ErbB signaling pathway (11)
- Fc epsilon RI signaling pathway (11)
- Fc gamma R-mediated phagocytosis (11)
- Glioma (11)
- GnRH signaling pathway (11)
- Insulin signaling pathway (11)
- Long-term potentiation (11)
- Melanoma (11)
- Natural killer cell mediated cytotoxicity (11)
- Neurotrophin signaling pathway (11)
- Non-small cell lung cancer (11)
- Prion diseases (11)
- Regulation of actin cytoskeleton (11)
- Renal cell carcinoma (11)
- T cell receptor signaling pathway (11)
- Toll-like receptor signaling pathway (11)
- VEGF signaling pathway (11)
- Vascular smooth muscle contraction (11)
- Alzheimer's disease (9)
- Parkinson's disease (9)
- Small cell lung cancer (9)
- Axon guidance (4)
- Spliceosome (2)
- Cytokine-cytokine receptor interaction (1)
- Jak-STAT signaling pathway (1)